Adults With Learning Disabilities, New Diabetes Have Shorter Time to Insulin Initiation
THURSDAY, Sept. 4, 2025 -- Adults with learning disabilities and newly diagnosed type 2 diabetes (T2D) have better short-term glycemic control, but also faster progression to severe diabetes and a higher risk for mortality than adults without learning disabilities, according to a study published online Sept. 2 in BMJ Open Diabetes Research & Care.
Archie Wing, from the London School of Hygiene & Tropical Medicine, and Rohini Mathur, from Queen Mary University of London, conducted an observational cohort study to assess the impact of living with learning disabilities on T2D control, management, and outcomes. The analysis included 280,300 adult primary care patients with newly diagnosed T2D (2004 to 2021; 0.74 percent with a learning disability) from electronic health records of the U.K. Clinical Practice Research Datalink.
The researchers found that in adjusted analyses, at five years postdiagnosis, people with learning disabilities had lower odds of poor glycemic control than those without learning disabilities (odds ratio, 0.81) and faster insulin initiation (hazard ratio, 1.20) versus those without learning disabilities. In adults with learning disabilities, the risks for all-cause and diabetes-related mortality were doubled (all-cause: hazard ratio, 2.15; diabetes-related: hazard ratio, 1.93). There was no difference observed in the risk for vascular complications.
"Our finding of higher rates of insulin initiation in those with learning disabilities warrants further investigation into whether this is due to poorer glycemic control at presentation (and therefore faster advancing type 2 diabetes) or due to having a greater degree of clinical surveillance," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Cancer Survival Lower in Rural Areas
WEDNESDAY, Oct. 1, 2025 -- Five-year cancer survival rates for each stage of cancer (localized, regional, and distant) is lower in nonmetropolitan areas for Black and White...
Metabolic Surgery Has Greater Long-Term Benefits Than GLP-1 Receptor Agonists
WEDNESDAY, Oct. 1, 2025 -- People with obesity and type 2 diabetes who undergo metabolic surgery live longer and face fewer serious health problems compared with patients treated...
Loss of Smell May Linger After COVID-19
WEDNESDAY, Oct. 1, 2025 -- Self-reported change or loss in smell or taste is an accurate signal of verified hyposmia after COVID-19, although there is also a high rate of hyposmia...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.